Carterra Live @ PEGS Europe 2021 | High-Throughput Antibody Screening | LSA Platform | Biotechnology

Discovery of Potent anti-PD-L1 Antibodies | High-Throughput Antibody Screening | LSA PlatformПодробнее

Screen biotherapeutic targets using Carterra's software suite | High-Throughput Antibody ScreeningПодробнее

Fastest Kinetic Screening for Antibody Discovery | Biotechnology | Biology Solutions | LSA PlatformПодробнее

HT-SPR Technology | High-Throughput Antibody Screening | Biology Solutions | LSA PlatformПодробнее

High res epitope binning | Antibody screening | High-Throughput Antibody Screening | LSA PlatformПодробнее

Carterra 2022 Symposium | High-Throughput Antibody Screening | LSA PlatformПодробнее

Therapeutic Antibodies in Post Genomics Era | High-Throughput Antibody Screening | LSA PlatformПодробнее

High Quality Therapeutic Antibodies | High-Throughput Antibody Screening | HT-SPR | LSA PlatformПодробнее

Therapeutic Antibody Screening in Post Genomics Era | HT-SPR | Carterra LSA Platform | BiotechПодробнее

Accelerate Antibody Discovery with HT Kinetic Screening of Phage Libraries | Carterra LSA PlatformПодробнее

Speed up Your Antibody Discovery | High-res Epitope Binning | Biology Solutions | LSA PlatformПодробнее

Carterra Scientist to Scientist Series | Therapeutic Antibody Screening | Biology SolutionsПодробнее

High Throughput Antibody Screening Using Synthetic Libraries Coupled with Kinetic & Binning AssaysПодробнее

Carterra LSA Overview | HT-SPR | Biotechnology | High-res Epitope Binning | Antibody ScreeningПодробнее

Improve Therapeutic Antibody Screening | Leverage HT-SPR to Complement AlphaLISA | LSA PlatformПодробнее

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike ProteinПодробнее

Advances in Antibody Discovery for Bispecific Therapeutics | Biology Solutions | Antibody ScreeningПодробнее